
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 952 | 952 | 1081 | 1400 | 2215 | 3302 |
Fund Return | -4.76% | -4.76% | 8.08% | 11.86% | 17.24% | 12.69% |
Place in category | 21 | 21 | 4 | 17 | 16 | 11 |
% in Category | 22 | 22 | 7 | 49 | 58 | 69 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BoseraYufu CSI 300 Index Fund A | 6.24B | 0.69 | 0.19 | 3.63 | ||
BoseraYufu CSI 300 Index Fund C | 6.24B | 0.59 | -0.21 | - | ||
Bosera Theme Industry Stock FdLOF | 5.37B | -3.49 | -8.43 | 2.53 | ||
Bosera MedicalHlth Care Set Secs A | 2.15B | 2.68 | -11.98 | 3.06 | ||
Bosera Emerging Growth Fund | 1.85B | 3.21 | -3.83 | 1.38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDIII | 14.6B | -8.82 | 11.29 | 16.87 | ||
HuaAn NASDAQ 100 Index QDII RMB | 7.19B | -8.46 | 11.57 | 16.43 | ||
Harvest U.S. Growth Equity QDII RMB | 6.74B | -10.76 | 12.34 | 13.47 | ||
Dacheng NASDAQ 100 Index Fund QDII | 4.19B | -9.26 | 11.56 | 15.96 | ||
Guotai NASDAQ 100 Index Fund QDII | 2.55B | -8.73 | 12.51 | 17.40 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 7.20 | 202.08 | -0.22% | |
NVIDIA | US67066G1040 | 6.26 | 112.20 | +1.35% | |
Microsoft | US5949181045 | 5.96 | 385.60 | -0.57% | |
Amazon.com | US0231351067 | 3.90 | 179.56 | -1.41% | |
Meta Platforms | US30303M1027 | 2.43 | 521.31 | -1.91% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Sell |
Technical Indicators | Sell | Strong Sell | Neutral |
Summary | Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review